Abstract 2149A: CRISPR/Cas9 mutagenesis invalidates a genetic target of clinical trials in cancer
Year: 2017
Type: conference-abstract
Source: Cancer Research
Institution: Cold Spring Harbor Laboratory
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2741990976
